Diuretic Use in Advanced CKD

Introduction to Diuretic Therapy

The American College of Cardiology recommends loop diuretics as the first-line treatment for fluid overload in patients with advanced CKD (GFR 18 mL/min), as they maintain efficacy even with markedly impaired renal function, but require higher doses and careful monitoring for complications 1
Loop diuretics should be used when there is clinical evidence of volume overload, including edema, hypertension requiring additional blood pressure control, and symptomatic fluid retention despite dietary sodium restriction 2

The National Kidney Foundation recommends torsemide over furosemide in advanced CKD due to its longer duration of action (12-16 hours vs 6-8 hours for furosemide), once-daily dosing, and more predictable bioavailability 1
Furosemide is acceptable if torsemide is unavailable, with twice-daily dosing preferred over once-daily in advanced CKD, and higher doses required at GFR <30 mL/min due to reduced tubular secretion 2, 1

The European Renal Association recommends adding sequential nephron blockade with a thiazide-like diuretic, amiloride, or spironolactone if inadequate response to high-dose loop diuretic, to block distal tubule reabsorption and counter hypokalemia 2, 1

The American Heart Association recommends checking serum potassium, serum sodium, and magnesium levels within 3 days and at 1 week after initiation of diuretic therapy, and ongoing monitoring at least monthly for the first 3 months and every 3 months thereafter 1, 2

The National Kidney Foundation recommends restricting sodium to <2.0 g/day (<90 mmol/day) to enhance the effectiveness of diuretic therapy, as diuretics cannot overcome excessive dietary sodium intake 2, 1